Wikidata entity: Q418130
C₂₂H₂₅F₂NO₄ (P274)
Quantities
| P4250 | defined daily dose | 5 |
| P2067 | mass | 405.175165 |
| P233 | canonical SMILES | String | C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O | ??? |
| P373 | Commons category | String | Nebivolol | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q280786 (terazosin) | terazosin |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q191521 (sildenafil) | sildenafil |
| P769 | significant drug interaction | ... | Q419939 (doxazosin) | doxazosin |
| P769 | significant drug interaction | ... | Q419944 (moxonidine) | moxonidine |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411887 (rivastigmine) | rivastigmine |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q418480 (tamsulosin) | tamsulosin |
| P769 | significant drug interaction | ... | Q2736873 (alfuzosin) | alfuzosin |
| P769 | significant drug interaction | ... | Q425296 (prazosin) | prazosin |
| P769 | significant drug interaction | ... | Q662511 ((RS)-propafenone) | (RS)-propafenone |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q816759 (beta blocker) | beta blocker |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q4008956 (vasodilator agent) | vasodilator agent |
| P2868 | subject has role | ... | Q50430367 (adrenergic beta-1 receptor agonists) | adrenergic beta-1 receptor agonists |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | nebivolol | ??? |
Why not click here or view trends?
log id: 2023939